These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1370635)

  • 1. Localization of a PlA1 epitope to the amino terminal 66 residues of platelet glycoprotein IIIa.
    Bowditch RD; Tani PH; Halloran CE; Frelinger AL; McMillan R; Ginsberg MH
    Blood; 1992 Feb; 79(3):559-62. PubMed ID: 1370635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 13-mer peptide straddling the leucine33/proline33 polymorphism in glycoprotein IIIa does not define the PLA1 epitope.
    Flug F; Espinola R; Liu LX; SinQuee C; DaRosso R; Nardi M; Karpatkin S
    Blood; 1991 May; 77(9):1964-9. PubMed ID: 1708295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.
    Newman PJ; Derbes RS; Aster RH
    J Clin Invest; 1989 May; 83(5):1778-81. PubMed ID: 2565345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response.
    Valentin N; Visentin GP; Newman PJ
    Blood; 1995 Jun; 85(11):3028-33. PubMed ID: 7756638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and purification of functional recombinant epitopes for the platelet antigens, PlA1 and PlA2.
    Barron-Casella EA; Kickler TS; Rogers OC; Casella JF
    Blood; 1994 Aug; 84(4):1157-63. PubMed ID: 7519475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein IIIa is responsible for the formation of the Pena/Penb alloantigen system.
    Wang R; Furihata K; McFarland JG; Friedman K; Aster RH; Newman PJ
    J Clin Invest; 1992 Nov; 90(5):2038-43. PubMed ID: 1430225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of binding of anti-PLA1 antibodies to platelets with monoclonal antibody LK-4. Evidence for multiple PLA1 receptor sites on platelet GPIIIa.
    Liu LX; Nardi MA; Casella JF; Karpatkin S
    Blood; 1996 Nov; 88(9):3601-7. PubMed ID: 8896429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive binding of a monoclonal antibody SZ-21 with anti-PLA1 antibodies and its potential for clinical application.
    Xi X; Zhao Y; Jiang H; Wu Q; Li P; Ruan C
    Nouv Rev Fr Hematol (1978); 1992; 34(3):239-42. PubMed ID: 1383923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of single amino acid substitutions on the formation of the PlA and Bak alloantigenic epitopes.
    Goldberger A; Kolodziej M; Poncz M; Bennett JS; Newman PJ
    Blood; 1991 Aug; 78(3):681-7. PubMed ID: 1713513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further characterization of the loop structure of platelet glycoprotein IIIa: partial mapping of functionally significant glycoprotein IIIa epitopes.
    Kouns WC; Newman PJ; Puckett KJ; Miller AA; Wall CD; Fox CF; Seyer JM; Jennings LK
    Blood; 1991 Dec; 78(12):3215-23. PubMed ID: 1720699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa.
    Furihata K; Nugent DJ; Bissonette A; Aster RH; Kunicki TJ
    J Clin Invest; 1987 Dec; 80(6):1624-30. PubMed ID: 2445781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody (LK-4) which differentiates PLA1 from PLA2 platelet extracts but not intact platelets.
    Liu LX; Nardi MA; Flug F; Karpatkin S
    Thromb Res; 1992 May; 66(4):309-20. PubMed ID: 1384161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a monoclonal antibody capable of differentiating platelet PLA1/PLA1, PLA1/PLA2 and PLA2/PLA2 genotypes.
    Liu LX; Nardi M; Flug F; Karpatkin S
    Br J Haematol; 1992 May; 81(1):113-7. PubMed ID: 1520609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPIIIa(90-102) and GPIIIa(631-653) epitopes as markers of conformational changes occurring during the activation of the glycoprotein IIb/IIIa complex.
    Niewiarowska J; Cierniewski CS
    Eur J Biochem; 1994 Sep; 224(3):803-9. PubMed ID: 7523118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPIIIa-related PLA1 antigens with different molecular weights: studies in platelets, endothelial cells, and megakaryocytes.
    Dancis A; Ehmann C; Ferziger R; Grima K; Karpatkin S
    Blood; 1988 Apr; 71(4):1056-61. PubMed ID: 3355887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies on the topography of human platelet glycoprotein IIb. Localization of monoclonal antibody epitopes and the putative glycoprotein IIa- and fibrinogen-binding regions.
    Calvete JJ; Arias J; Alvarez MV; Lopez MM; Henschen A; Gonzalez-Rodriguez J
    Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):767-75. PubMed ID: 1705115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactive antibodies between HIV-gp120 and platelet gpIIIa (CD61) in HIV-related immune thrombocytopenic purpura.
    Bettaieb A; Oksenhendler E; Duedari N; Bierling P
    Clin Exp Immunol; 1996 Jan; 103(1):19-23. PubMed ID: 8565280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on the topography of the N-terminal region of human platelet glycoprotein IIIa. Localization of monoclonal antibody epitopes and the putative fibrinogen-binding sites.
    Calvete JJ; Arias J; Alvarez MV; Lopez MM; Henschen A; González-Rodríguez J
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):457-63. PubMed ID: 1706596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivity of autoantibodies from chronic ITP patients with recombinant glycoprotein IIIa peptides.
    Bowditch RD; Tani P; McMillan R
    Br J Haematol; 1995 Sep; 91(1):178-84. PubMed ID: 7577629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid 489 is encoded by a mutational "hot spot" on the beta 3 integrin chain: the CA/TU human platelet alloantigen system.
    Wang R; McFarland JG; Kekomaki R; Newman PJ
    Blood; 1993 Dec; 82(11):3386-91. PubMed ID: 7694683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.